📰 Mark Redcliffe News
Mark Redcliffe News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mark Redcliffe. Real-time updates on events, politics, business and more.
April 20, 2023
ReGen III Corp. is pleased to announce it has entered into an investor relations agreement with IR Labs Inc. to provide the Company with investor relations services, with a primary focus on... | April 20, 2023
April 20, 2023
Vancouver, British Columbia--(Newsfile Corp. - April 20, 2023) - ReGen III Corp. (TSXV: GIII) (OTCQX: ISRJF) (FSE: PN4) ("ReGen III" or the "Company") is pleased to announce it has entered into an investor
April 4, 2023
 ReGen III Corp. is providing the following update.After the successful completion of offtake product testing in late 2020, ReGen III ratified a Sales, Purchase & Marketing Agreement in... | April 4, 2023
March 16, 2023
Vancouver, British Columbia--(Newsfile Corp. - March 16, 2023) - ReGen III Corp. (TSXV: GIII) (OTCQX: ISRJF) (FSE: PN4) ("ReGen III" or the "Company") is pleased to announce the closing of its non-brokered
July 6, 2022
Algernon Pharmaceuticals Inc said that it had included nicotinate and pamoate as novel salt forms of DMT as part of its intellectual property patent...
July 5, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
July 5, 2022
Algernon Pharmaceuticals Inc said that it had included nicotinate and pamoate as novel salt forms of DMT as part of its intellectual property patent...
July 5, 2022
Algernon Pharmaceuticals Inc said that it had included nicotinate and pamoate as novel salt forms of DMT as part of its intellectual property patent...
April 19, 2022
Vancouver, British Columbia--(Newsfile Corp. - April 19, 2022) - ReGen III Corp. (TSXV: GIII) (OTCQB: ISRJF) (FSE: PN4) ("ReGen III" or the "Company") is pleased to announce the appointment of Kimberly
April 11, 2022
Vancouver, British Columbia--(Newsfile Corp. - April 11, 2022) - Further to its news release dated April 8, 2022, ReGen III Corp. (TSXV: GIII) (OTCQB: ISRJF) (FSE: PN4) ("ReGen III" or the "Company")